From France, yet more evidence of how many asymptomatic cases there may be. (Medrxiv Paper) Officials conducted a study of students, siblings, parents and staff at a high school in a town. They tested the group for antibodies. In addition, they examined blood donations at blood banks for the presence of those antibodies. 661 were tested and 171 had antibodies, or 26%. In students, the infection rate was 41% and 11% in parents and siblings. The rate of antibodies in blood bank samples was 3%. No one died. 68% of participants reported respiratory symptoms (not necessarily from the virus) from January 13 to one week before the blood sampling. Major symptoms were reported by 49% and minor symptoms by 20%. The rate of people with no symptoms was 32%, but almost all those who had symptoms had a mild illness. Ten people said they went to the hospital, nine tested positive, for a hospitalization rate of 5.3% among the infected. Among the people who tested positive, 71% said they had a major symptom, 12% a mild one and 17% none. The students and staff had a higher rate of infection than did parents and siblings. Now here is something interesting, smokers had a much lower rate of infection. Since participation was voluntary, and those who though they have been sick may have been more likely to participate, extrapolation may be limited. But once again we see that large numbers of people may have been infected and more critically, almost all had non-serious illnesses. So all those scary modeling parameters need to be adjusted appropriately.
A French Study on Undetected Cases
By Kevin RocheApril 24, 2020Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 27, 2023
Why You Can’t Trust People Who Make Up Stuff About Vax Safety
A couple of studies offer a far better explanation for heart issues in athletes and…
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…